Non categorizzato Merck to buy biotech firm EyeBio for up to $3B Maggio 29, 2024 0 commenti Merck & Co. Inc. announced on Wednesday that it will acquire all outstanding shares of Eyebiotech Ltd. (EyeBio) for up to $3 billion, including an upfront payment of $1.3 billion in cash and a fur… About the author:
Get involved!
Comments